The success of this study could revolutionize the standard HIV care for patients in Africa and reduce HIVrelated mortality rates. The REVIVE study is a collaborative research trial between the University of Cape Town and the Population Health Research Institute aimed at testing the effectiveness of a costeffective antibiotic treatment for advanced HIV patients. The trial, funded by the Bill & Melinda Gates Foundation, aims to investigate if administering the antibiotic azithromycin daily over a fourweek period can significantly lower death rates among adults suffering from advanced HIV.
The City of Cape Town is taking significant steps to combat HIV and TB by implementing new policies and guidelines, such as Post Exposure Prophylaxis (PEP) and PreExposure Prophylaxis (PrEP) to motivate people to evaluate their HIV status and offer alternatives for those at risk. The City’s approach focuses on social, biomedical, and behavioural aspects and serves as a model for other cities. The City has seen a substantial increase in HIV selftests, and prevention strategies aim to reduce the untested population. The City’s dedication to combating HIV and TB goes beyond biomedical and behavioural approaches and addresses the social determinants of health.
On May 13th, the Deputy Minister of Social Development, Mme Hendrietta BogopaneZulu, in collaboration with USAID, will launch ChommY. This pioneering program aims to empower children aged between 10 and 14 years from Ekurhuleni hostels. The initiative will be launched at the Vosloorus Civic Centre under the theme “Invest in my Future…Protect me Today.”
Honeybees play a vital role in maintaining the health of the planet’s ecosystem. They are responsible for pollinating a third of the food we eat, including fruits, vegetables, and nuts. However, honeybees are facing numerous threats, such as habitat loss, pesticides, climate change, and disease, which have contributed to the decline in bee populations.